To the full analysis
Atria stock: growth
ATRAV.HEAtria reported $2.01B in revenue for fiscal 2025, up 3.3% on the prior year, up 3.8% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
2.7%
per year from 2006 to 2025, per share 1.3%
Earnings (Annual rate)
2.6%
per year from 2006 to 2025, per share −20.6%
Free cash flow (Annual rate)
17.4%
per year from 2006 to 2025, per share 15.9%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 3.8% | 3.1% | 2.7% |
| Revenue per share | 3.7% | 3.0% | 1.3% |
| Earnings | 12.2% | 11.4% | 2.6% |
| Earnings per share | 12.2% | 11.4% | −20.6% |
| Free cash flow | 1.4% | 5.0% | 17.4% |
| Free cash flow per share | 1.4% | 5.0% | 15.9% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $1.22B | $27.82M | $3.44M |
| 2007 | $1.41B | $73.9M | −$4.72M |
| 2008 | $1.5B | $12.65M | −$30.88M |
| 2009 | $1.46B | $7.84M | $32.57M |
| 2010 | $1.44B | −$4.68M | $5.63M |
| 2011 | $1.44B | −$7.34M | $17.83M |
| 2012 | $1.49B | $10.88M | $54.55M |
| 2013 | $1.56B | −$4.81M | $55.66M |
| 2014 | $1.58B | $29.01M | $64.59M |
| 2015 | $1.49B | $15.29M | $44.78M |
| 2016 | $1.5B | $20.16M | $24.61M |
| 2017 | $1.59B | $28.65M | $12.59M |
| 2018 | $1.59B | $18.13M | $2.99M |
| 2019 | $1.61B | $16.72M | $54.38M |
| 2020 | $1.67B | $25.39M | $68.02M |
| 2021 | $1.71B | −$5.98M | $35.87M |
| 2022 | $1.88B | −$4.27M | −$141.11M |
| 2023 | $1.94B | −$21.94M | −$18.03M |
| 2024 | $1.95B | $43.99M | $59.51M |
| 2025 | $2.01B | $45.1M | $73.02M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 18 Oct 2026)
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.